Products

What will AGI do for Balofloxacin?

This classification denotes a quinolone antibiotic with the molecular formula C20H24FN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q022B63JPM, chemically known as 3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-(methylamino)-1-piperidinyl)-4-oxo- but generally known as balofloxacin, which bears US NIH Compound Identifier 65958. Balofloxacin most often comes in base and hydrate forms. European Medicines Agency schedules Balofloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06091MIG. The term BALOFLOXACIN is an International Non-Proprietary Name. BALOFLOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule balofloxacin under HS 29334910 and SITC 51575. As of Q4 2014, BALOFLOXACIN remains the US FDA Preferred Term for this commodity. Balofloxacin bears US NLM identifiers UMLS ID C0173239 and NCI Concept Code C72631. SMILES: FC1C(N2CC(NC)CCC2)C(OC)C2N(C3CC3)CC(C(=O)C2C1)C(=O)O.